References
- Mackenzie AH. Antimalarial drugs for rheumatoid arthritis. Am J Med 1983; 75: 48–58
- Lanham J G, Hughes G RV. Antimalarial therapy in SLE. Clin Rheum Dis 1982; 8: 279–98
- Zabel H, Nietzki M. Sensitization to light during chloroquine diphosphate therapy. Excerpta Med 1962; 16: 108
- Giglioli G, Dyrting A E, Rutten F J, Gentle G HK. Photo-allergic dermatitis during a chloroquinized salt anti-malaria campaign in Guyana. Trans R Soc Trop Med Hyg 1967; 61: 313–30
- Van Weelden H, Bolling H H, De la Faille H B, van der Leun JC. Photosensitivity caused by chloroquine. Arch Dermatol 1982; 118: 290
- Cahn M M, Levy E J, Shaffer B. Polymorphous light eruption. The effect of chloroquine phosphate in modifying reactions to ultraviolet light. J Invest Dermatol 1956; 26: 201–7
- Sams WM. Chloroquine: its therapeutic use in photosensitive eruptions. Int J Dermatol 1976; 15(2)99–111
- Dubois EL. Antimalarials in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum 1978; 8: 33–51
- Murphy G M, Hawk J LM, Magnus IA. Hydroxychloro-quine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Br J Dermatol 1987; 116: 379–86
- Bagnall AW. The value of chloroquine in rheumatoid diseases. Canad MAJ 1957; 77: 182–94
- Morison W L, Stern RS. Polymorphous light eruption. A common reaction uncommonly recognized. Acta Derm Venereol 1982; 62: 23740
- Ros A M, Wennersten G. Current aspects of polymorphous light eruption in Sweden. Photodermatol 1986; 3: 298–302
- Wysenbeek A J, Block D A, Fries JF. Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 461–3
- Schaffer B, Cahn M M, Levy EJ. Absorption of antimalarial drugs in human skin. J Invest Dermatol 1958; 30: 341–5
- Tanenbaum L, Tuffanelli DL. Antimalarial agents, Chloroquine, hydroxychloroquine and quinacrine. Arch Dermatol 1980; 116: 587–91